Csf-targeted proteomics indicate amyloid-beta ratios in patients with alzheimer s dementia spectrum

HIGHLIGHTS

  • who: Ali Rezaei and colleagues from the NeuroTRACT Association, Students` Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran have published the Article: CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer s Dementia Spectrum, in the Journal: International Journal of Alzheimer`s Disease
  • what: The authors aimed to investigate the correlations between several targeted proteomics in CSF samples with Au03b2 ratios and cognitive scores in patients in AD spectrum to search for potential early diagnostic utility. The authors used CDR, ADAS, and MMSE to assess cognition, which are valid assessment tools . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?